Cancer BiologyMolecular OncologyPeer-reviewed
CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds
Sandra Amarilla‐Quintana, Paloma Navarro, Iván Hernández…·Ignacío Pérez de Castro
This study uses CRISPR to eliminate the FOXL2 c.402C>G mutation in granulosa tumor cells, reducing malignancy and identifying anti-tumoral compounds.
2 citations